Search research articles
Contact Us
Filters
Showing results (1301-1310 of 1,329) with videos related to
Page
of 133
Sort By:
HGG Advances
|
November 1, 2025
Resolving SLC6A1 variable expressivity with deep clinical phenotyping and Drosophila models
Kristy L Jay, Nikhita Gogate, Paige I Hall, et al.
Cell Reports
|
July 22, 2023
A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins
Annabel Guichard, Shenzhao Lu, Oguz Kanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang, Shruti Malu, Jodi A McKenzie, et al.
Science Advances
|
November 25, 2015
Lunar impact basins revealed by Gravity Recovery and Interior Laboratory measurements
Gregory A Neumann, Maria T Zuber, Mark A Wieczorek, et al.
American Journal of Human Genetics
|
July 23, 2019
De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
Oguz Kanca, Jonathan C Andrews, Pei-Tseng Lee, et al.
Cell Host & Microbe
|
October 31, 2024
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Nature Genetics
|
December 8, 2015
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
Haifa H Jabara, Steven E Boyden, Janet Chou, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 22, 2001
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution
D L Musso, M W Andersen, R C Andrews, et al.
Cell Research
|
September 5, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Nicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Page
of 133
Search research articles
Search
Showing results (1301-1310 of 1,329) with videos related to
Sort By:
Page
of 133
HGG Advances
|
November 1, 2025
Resolving SLC6A1 variable expressivity with deep clinical phenotyping and Drosophila models
Kristy L Jay, Nikhita Gogate, Paige I Hall, et al.
Cell Reports
|
July 22, 2023
A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins
Annabel Guichard, Shenzhao Lu, Oguz Kanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang, Shruti Malu, Jodi A McKenzie, et al.
Science Advances
|
November 25, 2015
Lunar impact basins revealed by Gravity Recovery and Interior Laboratory measurements
Gregory A Neumann, Maria T Zuber, Mark A Wieczorek, et al.
American Journal of Human Genetics
|
July 23, 2019
De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
Oguz Kanca, Jonathan C Andrews, Pei-Tseng Lee, et al.
Cell Host & Microbe
|
October 31, 2024
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D G Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Nature Genetics
|
December 8, 2015
A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
Haifa H Jabara, Steven E Boyden, Janet Chou, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 22, 2001
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution
D L Musso, M W Andersen, R C Andrews, et al.
Cell Research
|
September 5, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Nicolas Jacquelot, Takahiro Yamazaki, Maria P Roberti, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Page
of 133